Swil-NewsWED · OCT 21 · 2026 · ISSUE № 2026.10.21
Same-day topicsGeneralFinance & marketsAI & techScience & researchCurrentCrypto & Web3Energy & climateAuto & mobilityGaming & entertainmentSupply chain & manufacturingSports, health & nutrition
Back to Science & researchBack to home

October 21, 2026 · Science & Research Daily Digest

A digest of science, space, biomedicine, and climate research for October 21, 2026, with summaries, links, and commentary.


I. Space and Astronomy

1. Perseverance's odometer hit 45.22 kilometers on Sol 2006, a new off-world driving record (Spaceflight)

Summary:

NASA Science posted a Mars 2020 mission blog on October 21. The text is signed October 12 by Vandi Verma, chief engineer for robotic operations at the Jet Propulsion Laboratory. It says that on Sol 2006 (October 11, 2026) Perseverance's odometer reached 45.22 kilometers (28.10 miles), farther than any spacecraft has driven on another celestial body. The engineering twin on Earth received a Guinness World Records plaque for the mark. On Sol 1947, two months earlier, about 200 meters still remained, and the rover spent that margin on short drives, rock abrasions, and proximity science at an outcrop the team did not want to leave. After thousands of simulations, the team raised the tilt limit to 24 degrees, cut belly-pan clearance to 20 centimeters, and turned on onboard global localization: a high-speed commercial processor inside the Ingenuity helicopter base station compares ground and orbital images and fixes the rover's position at the end of a drive.

Links:

Commentary:

The 45.22 kilometers are distance already driven as of October 11, and the plaque went to the twin on Earth; the update is about driving margin, not a new sample-science result.


2. USTC reports AT2023uqm, a star torn repeatedly by a black hole on a roughly 527-day cycle (Astronomy)

Summary:

On October 21, the astronomy department at the University of Science and Technology of China announced a Science Bulletin paper on AT2023uqm from the Wide Field Survey Telescope science team. The nuclear transient, at a redshift of about 0.238, has produced at least five optical flares. The university calls it the second known extragalactic optical periodic transient. ATLAS first found it in October 2023; earlier, fainter flares were recovered in Zwicky Transient Facility archives, and the fifth arrived on schedule in April 2025. In the observer frame the period is about 527 days, each flare releases about 1.7 times the energy of the previous one, and each shows a double peak separated by about 17 to 20 days. For the fifth flare, the optical-ultraviolet blackbody temperature was about 18,000 K and the peak luminosity about 10^44.5 erg/s. Yibo Wang is first and corresponding author, with Tinggui Wang as the other corresponding author. The release says that if the star is low-mass, at most one or two flares remain, and that the next one, if it occurs, would fall around September 2026; the team says observations were deployed in advance.

Links:

Commentary:

The 1.7-fold rise in energy fits a repeating partial disruption in which the star is being taken apart; the double peak still has two readings, fallback or disk collisions, and the October 21 release does not say whether the flare expected around September 2026 was seen.


II. Biomedicine

3. FDA approves Hibsago, the first antisense oligonucleotide for chronic hepatitis B (Drug)

Summary:

On October 20, the U.S. Food and Drug Administration approved GSK's Hibsago (bepirovirsen) injection, with existing antiviral therapy, for certain adults with chronic hepatitis B and no cirrhosis. It is the first antisense oligonucleotide the FDA has approved for chronic hepatitis B. Patients must already have taken HBV antiviral therapy for at least six months, have suppressed virus in the blood, and have hepatitis B surface antigen at or below 3,000 IU/mL. The drug is injected under the skin for up to 24 weeks, and the existing medicine continues for at least 24 weeks after the last dose. Across two placebo-controlled trials, 24% of patients who received Hibsago met the requirements to stop their existing medicine, compared with none on placebo. Twenty-four weeks after all hepatitis B treatment stopped, 19% of patients who received Hibsago still had the virus under control, and HBsAg was undetectable in their blood. The label carries a boxed warning for serious liver reactions and low platelet counts. The FDA also authorized the Roche Elecsys HBsAg II quant II RxDx assay as a companion diagnostic.

Links:

Commentary:

The 19% figure is the share of Hibsago recipients who still met viral control 24 weeks after all treatment stopped, not a rate for every person with chronic hepatitis B, and the release does not give the enrollment of the two trials.


4. Andes virus hides its receptor site in a pocket formed by four Gn protomers (Virology)

Summary:

Nature on October 21 published an open-access paper by Leandro Battini, Kartik Chandran, Jason S. McLellan, Pablo Guardado-Calvo, and colleagues. New World hantaviruses, including Andes virus, enter cells through the surface receptor protocadherin-1 (PCDH1), and no approved therapeutics exist. A near-atomic structure shows PCDH1 engaging, asymmetrically, a deep central pocket made by four Gn protomers, which is why only intact particles or soluble tetramers recognize the receptor. Mutagenesis identified three Gn loops that shape the site and showed that PCDH1 binding can be transferred onto Old World glycoproteins. Structures and functional tests of four neutralizing antibodies show two ways of blocking the receptor: occluding the binding site, or sterically keeping the receptor from engaging.

Links:

Commentary:

The paper maps receptor geometry on the spike and how antibodies block it; it does not report a drug that has entered clinical trials.


5. CD51 splits astrocytes into a synapse-building group and a group that changes hippocampal plasticity (Neuroscience)

Summary:

Nature published online on October 21 an open-access paper by Junsung Woo, Michael R. Williamson, Benjamin Deneen, and colleagues. They built a CD51-FLP mouse so CD51-positive and CD51-negative astrocytes can be compared directly in living circuits. The two populations differ in morphology, physiology, and development in both cortex and hippocampus. Functionally, CD51-positive cells selectively promote synapse formation in the developing cortex and circuit plasticity in the hippocampus. The mechanisms separate: cortical synapse formation runs through glypican 6, while hippocampal plasticity is driven by CD51 itself. In injury, CD51-positive astrocytes promote functional recovery after stroke through stronger synaptic remodeling.

Links:

Commentary:

The recovery effect is synaptic remodeling in a mouse stroke model; the paper does not give a cell dose or a clinical endpoint for people.


6. Cold drives worm muscle to make BH2, which travels to the intestine and neurons, extends lifespan, and steadies proteins (Metabolism)

Summary:

Nature on October 21 published an open-access paper by Hyun Ju Lee, David Vilchez, and colleagues. Moderate cold extends lifespan across species, and the mechanism had been unclear. In Caenorhabditis elegans, cold upregulates the biopterin-synthesis enzyme CAT-4, the counterpart of human GCH1, and raises dihydrobiopterin (BH2). Muscle makes BH2 and ships it to the intestine and neurons, where the salvage enzyme DHFR-1 converts it to tetrahydrobiopterin (BH4). BH4 is an essential cofactor for the phenylalanine hydroxylase PAH-1, promoting tyrosine synthesis and extending lifespan. The same axis limits disease-related protein aggregation and later neuronal dysfunction during aging. Raising BH2 synthesis in muscle alone is enough to extend lifespan and suppress pathological aggregation in distant tissues, even at normal or higher temperatures. In human cells, BH2 or tyrosine supplementation reduces aggregation of polyglutamine-expanded proteins linked to Huntington's disease and of mutant TDP-43 and FUS linked to amyotrophic lateral sclerosis.

Links:

Commentary:

The causal chain for lifespan and proteostasis is in the worm; the human-cell result is less aggregation, not a clinical improvement.


III. Climate and Environment

7. UNEP: current policies put warming at 2.8°C this century, and the low-overshoot path needs an 18% cut by 2030 (Climate)

Summary:

On October 21 in Nairobi, the UN Environment Programme released the Emissions Gap Report 2026: The Point of Return. If current policies continue, warming could reach 2.8°C within this century and rise further after that. If all nationally determined contributions are delivered and similar efforts continue, warming is limited to 2.6°C. In the most optimistic case, those pledges plus additional net-zero targets limit warming to 2.1°C this century. The outcomes are worse than last year's because the United States withdrew from the Paris Agreement and historical-emission estimates were revised; new NDCs since the last report barely moved the projections. The report's lowest-possible 1.5°C overshoot pathway peaks at 1.7°C to 1.8°C around mid-century and returns to or below 1.5°C by 2100 with about a 50% chance. Relative to 2025, that requires greenhouse-gas cuts of 18% by 2030, 45% by 2035, and 69% by 2040. Full delivery of current NDCs cuts emissions only 5% to 8% by 2030 and 11% to 15% by 2035. The pathway also needs about 320 gigatonnes of CO2 removed and stored permanently this century, roughly eight years of 2024 global CO2 emissions. Every five years of CO2 emissions at today's level pushes peak warming up by about 0.1°C. Since the Paris Agreement, renewable electricity capacity has grown about three times faster than anticipated, and solar photovoltaics about seven times faster. UN News says the second Global Stocktake begins next month at COP31 in Antalya, Turkey.

Links:

Commentary:

The figures 2.8°C, 2.6°C, and 2.1°C belong to current policies, full NDC delivery with similar efforts continued, and those pledges plus extra net-zero targets; 1.7°C to 1.8°C is an overshoot scenario that still requires deep early cuts and large-scale carbon dioxide removal.


8. The Amazon's 15-year mean is a net source of 0.32±0.08 PgC per year, and fire dominates (Ecology)

Summary:

Nature on October 21 published an open-access paper by Luciana V. Gatti, Carlos Nobre, and colleagues that reconstructs 15 years of Amazon carbon fluxes from atmospheric CO2 measurements. The 15-year mean balance is 0.32±0.08 PgC per year: fire at 0.40±0.07 PgC per year and net biome exchange at −0.08±0.12 PgC per year, a net source, with forest uptake increasingly unable to offset emissions. The authors split the years into three groups. Wetter years with lower human activity (2011–2014, 2017, and 2018) average 0.11±0.08 PgC per year. The years 2019–2022, with lower climate stress but high deforestation and degradation, average 0.43±0.13 PgC per year. Warm, dry years with intense biomass burning (2010, 2015, 2016, 2023, and 2024) average 0.49±0.07 PgC per year. The last two groups do not differ significantly, and net biome exchange is close to neutral in all three. Long-term deforestation and degradation have also cut annual precipitation by about 8% and dry-season peak precipitation by about 20% over 46 years, while raising annual mean temperature by 1.13±0.13°C and dry-season temperature by 1.81±0.18°C.

Links:

Commentary:

The 0.32 PgC per year is a 15-year mean net source, not one year's emissions; dry years run higher, and the paper also says the last two groups do not differ significantly, with direct human activity still the main risk.


IV. Protein Design and Fundamental Physics

9. Westlake's Pinal designs proteins from plain language, and one H-protein raises a carbon-fixation titre 1.7-fold (Protein)

Summary:

Nature on October 21 published a paper by Fengyuan Dai, Shiyang You, Fajie Yuan, and colleagues, with Fajie Yuan of Westlake University among the corresponding authors. Pinal is a 16-billion-parameter foundation model trained on 1.7 billion synthetic protein-text pairs. It turns a natural-language description of a desired function into a candidate protein sequence and structure. In computational tests, candidates combined high predicted foldability, alignment with the functional description, and sequence diversity. Experiments covered four tasks: a fluorescent protein, a polyethylene terephthalate hydrolase, an alcohol dehydrogenase, and a metabolic H-protein. The intended function was observed in each case, and both designed enzymes showed catalytic activity. Without iterative experimental optimization, a Pinal-designed H-protein raised product titre 1.7-fold relative to the matching native Escherichia coli H-protein in a multi-enzyme CO2-fixation pathway.

Links:

Commentary:

The 1.7-fold gain is titre against the native H-protein in one multi-enzyme carbon-fixation pathway, not a gain shared by all four tasks, and it is not a drug or plant yield.


10. The University of Washington and NVIDIA release open model RFD4-Proteina, with design success up five- to tenfold (Protein)

Summary:

On October 21, the University of Washington School of Medicine Institute for Protein Design released RFD4-Proteina, an open generative model built with NVIDIA. It joins the institute's RosettaFold Diffusion line with NVIDIA's Proteina-Complexa and is released under a BSD-3 license. On harder problems the model can spend more computation, and it rewrites a protein's sequence and structure together with the structures of molecules it binds. The institute says that on computational benchmarks the design success rate is five- to tenfold higher than previous models, and candidates are generated five to ten times faster. Bench tests found that the proteins behaved as intended. The project was led by UW doctoral students Nathaniel Corley, Maxwell Kazman, and Rafi Brent with Oxford visiting student Kieran Didi. Institute director David Baker, recipient of the 2024 Nobel Prize in Chemistry, took part in the release. The newsroom quotes student Seth Woodbury saying an enzyme that degrades a pesticide, designed in a few days, performed many-fold better than his previous best, which had taken months. A separate glycan-control task shrank from months to under a week. The release does not link a peer-reviewed paper.

Links:

Commentary:

The five- to tenfold figures are benchmark success and generation speed against earlier models; the pesticide enzyme's "many-fold" gain is not given as a number, and until a paper is public this remains an institutional model release.


11. One positron in a 5.6-tesla Penning trap reaches a resolved cyclotron quantum state (Physics)

Summary:

Physical Review Letters on October 21 published a paper by T. G. Myers, L. Soucy, B. A. D. Sukra, B. Sinha, and Gerald Gabrielse of Northwestern University, with a Nature news story the same day. They built a one-positron quantum cyclotron: a single positron suspended in the magnetic field of a Penning trap, with its lowest cyclotron and spin levels fully resolved. The demonstration uses a 5.6-tesla field from a 4.2-kelvin superconducting solenoid. A sealed vacuum enclosure and the trap electrodes are held at 300 millikelvin by a dilution refrigerator. The positron comes from sodium-22 beta decay, with kinetic energy up to about 546 keV, and is slowed in a tungsten crystal until its thermal cyclotron energy is 26 microelectronvolts. The paper says a single positron can be suspended indefinitely, opening quantum measurements of the positron magnetic moment at a precision far above classical cyclotron motion, for comparison with an electron quantum cyclotron and a test of CPT symmetry in the lepton sector of the Standard Model. Nature reports that the team has trapped and cooled the positron for months, and that the magnetic moment can be measured in electrons and positrons with about 10,000 times the precision of proton-antiproton comparisons. The measurement itself is the next step.

Links:

Commentary:

This paper delivers a single-positron trap with resolved quantum states, not a new published value for the positron magnetic moment; the factor of 10,000 is the precision such a measurement could reach relative to proton-antiproton comparisons.


12. An all-antiferromagnetic tunnel junction reaches 363% room-temperature magnetoresistance, and current flips the octupole (Spintronics)

Summary:

Nature on October 21 published a paper by Jaimin Kang, Mohammad Hamdi, Pedram Khalili Amiri, and colleagues. Ferromagnetic tunnel junctions are read out by tunneling magnetoresistance and written by spin-transfer torque. All-antiferromagnetic junctions, with zero net magnetization, were long assumed unable to support a sizable write operation. The authors demonstrate what they call octupole-driven spin-transfer torque in nanoscale PtMn3|MgO|PtMn3 junctions built from a chiral antiferromagnet and magnesium oxide. Tunneling magnetoresistance is 363% at room temperature, and switching current densities are on the order of 10 MA/cm2. Theory explains the torque as an imbalance between intra- and inter-sublattice spin currents, equivalently a nonzero cluster-octupole polarization in each PtMn3 layer.

Links:

Commentary:

The 363% and the current density on the order of 10 MA/cm2 are room-temperature device figures for these nanoscale junctions; the paper presents a materials platform toward denser magnetic memory and room-temperature terahertz technology, not a memory already in production.


Today's Summary

  • Space and astronomy: On October 11 (Sol 2006), Perseverance's odometer reached 45.22 kilometers off Earth. The same day's university release on AT2023uqm describes repeated flares on a roughly 527-day cycle, each about 1.7 times the energy of the last.
  • Biomedicine: On October 20 the FDA approved Hibsago, the first antisense oligonucleotide for chronic hepatitis B; 19% of recipients still met viral control 24 weeks after all treatment stopped. Nature the same day gave a near-atomic structure of Andes virus bound to PCDH1 and split CD51-positive astrocytes into synapse-building and plasticity pathways.
  • Climate: UNEP put warming under current policies at 2.8°C this century. A return to 1.5°C by 2100 with about a 50% chance requires an 18% emissions cut by 2030 relative to 2025. The Amazon's 15-year mean is a net source of 0.32±0.08 PgC per year, dominated by fire.
  • Basic research: A Pinal-designed H-protein raised titre 1.7-fold in one carbon-fixation pathway. RFD4-Proteina raised design success five- to tenfold on computational benchmarks, and the release does not yet attach a journal paper. A one-positron quantum cyclotron resolved cyclotron states at 5.6 tesla and 300 millikelvin. An all-antiferromagnetic tunnel junction reached 363% room-temperature magnetoresistance.

Daily Framing:

October 21 was an overshoot-and-return day: the emissions-gap report put current-policy warming at 2.8°C this century while spelling out the cuts required to come back to 1.5°C, as Perseverance's off-world mileage, a one-positron quantum cyclotron, and a hantavirus receptor structure each moved a measurement or an intervention onto a scale not reached before.


This digest is compiled from real-time search results and is for reference only.

MORE FROM SCIENCE & RESEARCH

Oct 20, 2026

October 20, 2026 · Science & Research Daily Digest

A digest of science, space, biomedicine, and climate research for October 20, 2026, with summaries, links, and commentary.
Oct 19, 2026

October 19, 2026 · Science & Research Daily Digest

A digest of science, space, biomedicine, and climate research for October 19, 2026, with summaries, links, and commentary.
Oct 18, 2026

October 18, 2026 · Science & Research Daily Digest

A digest of science, space, biomedicine, and climate research for October 18, 2026, with summaries, links, and commentary.